HCMT
KYNB

Highland Capital Management (Texas)’s Kyntra Bio KYNB Stock Holding History

Highland Capital Management (Texas)’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,864
Closed -$992K – 251
2016
Q1 		$992K Sell
1,864
-14,693
-89% -$7.32M 0.04% 169
2015
Q4 		$12.6M Buy
+16,557
New +$11M 0.4% 75

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Highland Capital Management (Texas)'s KYNB Position: Q2 2016 in Review

Highland Capital Management (Texas) sold out of Kyntra Bio (KYNB) in Q2 2016, closing a stake of 1,864 shares — an estimated $992K sold.

Highland Capital Management (Texas) first reported a position in KYNB in Q4 2015 and held it in 2 quarters. The position peaked at $12.6M in Q4 2015. 146 funds tracked by Wall St. Rank hold KYNB as of Q2 2016.

  • Highland Capital Management (Texas) reported no remaining Kyntra Bio position as of Q2 2016 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 1,864 Kyntra Bio shares in Q2 2016, an estimated $992K.
  • Highland Capital Management (Texas) first reported a position in Kyntra Bio in Q4 2015 and held it in 2 quarters.
  • Highland Capital Management (Texas)'s Kyntra Bio position peaked at $12.6M in Q4 2015.
  • 146 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2016.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2016, filed 15 Aug 2016.